7 Results for "

kb NB 142-70

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "kb NB 142-70" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-15528
CAS No.: 1233533-04-4
Purity:  98.08%
Target:  

PKD

Research Areas:  

Cancer

kb NB 142-70 is a potent PKD inhibitor, with IC50s of 28.3, 58.7 and 53.2 nM for PKD1, PKD2, and PKD3, respectively. kb NB 142-70 also has antitumor activity.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-14270
CAS No.: 53882-12-5
Purity:  98.02%
Synonyms: U-42585E free acid
Target:  

Histamine Receptor

Lodoxamide (U-42585E free acid) is an antiallergic compound acting as a mast-cell stabilizer for the treatment of asthma and allergic conjunctivitis.
loading...
    loading...
Cat. No.: HY-15528R
CAS No.: 1233533-04-4
Target:  

PKD

Research Areas:  

Cancer

kb NB 142-70 (Standard) is the analytical standard of kb NB 142-70. This product is intended for research and analytical applications. kb NB 142-70 is a potent PKD inhibitor, with IC50s of 28.3, 58.7 and 53.2 nM for PKD1, PKD2, and PKD3, respectively. kb NB 142-70 also has antitumor activity.
loading...
    loading...
Cat. No.: HY-NP142
Synonyms: MA-BSA
Methamphetamine-BSA is a protein consists of Methamphetamine and Bovine Serum Albumin (BSA). Methamphetamine-BSA is an antigen to generate specific antibodies for the detection of Methamphetamine in biological samples .
loading...
    loading...
Cat. No.: HY-RS14270
Research Areas:  

Others

TBX1 Human Pre-designed siRNA Set A contains three designed siRNAs for TBX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-14270R
CAS No.: 53882-12-5
Synonyms: U-42585E free acid (Standard)
Lodoxamide (Standard) is the analytical standard of Lodoxamide. This product is intended for research and analytical applications. Lodoxamide (U-42585E free acid) is an antiallergic compound acting as a mast-cell stabilizer for the treatment of asthma and allergic conjunctivitis.
loading...
    loading...
Cat. No.: HY-L142
159 compounds

Tuberculosis (TB), usually caused by bacteria (Mycobacterium tuberculosis), is an infectious disease that mainly affects the lungs. According to the statistics of the World Health Organization (WHO), 10 million people suffer from tuberculosis every year, and 1.5 million people die of tuberculosis every year, which makes tuberculosis the number one killer of infectious diseases.

Tuberculosis can be cured through the standard 6-month course of treatment of four kinds of antibiotics. Common drugs include rifampicin and isoniazid. In some cases, TB bacteria do not respond to standard drugs, that is, patients with drug-resistant tuberculosis. The treatment of drug-resistant tuberculosis takes longer and is more complex. In the face of the resurgence of tuberculosis in the world and the rapid emergence of multi drug resistant tuberculosis, it is very important to develop new anti-tuberculosis drugs or new clinical treatment schemes for existing anti mycobacterium drugs.

MCE supplies a unique collection of 159 compounds with clear anti-tuberculosis activity. MCE Anti-tuberculosis Compound Library is a useful tool for anti-tuberculosis related research and anti-tuberculosis drug development